Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: Correlation with clinicopathological findings and clinical course

Heart

Volumn 81, Issue 2, 1999, Pages 153-159

  Yazaki, Y ^a   Isobe, M ^b   Takahashi, W ^a   Kitabayashi, H ^b   Nishiyama, O ^a   Sekiguchi, M ^b   Takemura, T ^a  

^a National Hospital Organization   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

Fatty acid metabolism; Idiopathic dilated cardiomyopathy; methyl iodophenyl pentadecanoic acid

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; FATTY ACID; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; FATTY ACID METABOLISM; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE BIOPSY; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG CAPILLARY PRESSURE; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033018090     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.2.153     Document Type: Article

References (29)

1. 1 Opie LH. Metabolism of the heart in health and disease. Am Heart J 1968;76:685.
2. 2 Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Gardiovasc Dis 1972;15:685-98.
3. 3 Rellas JS, Corbett JR, Kulkarni P, et al. Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. Am J Cardiol 1983,52:1326-32.
4. 4 van der Wall EE, Heidendal GAK, den Hallander W, et al. I-123-labeled hexadecanoic acid in comparison with thallium-201 for myocardial imaging in coronary artery disease. Eur J Nucl Med 1983;5:391-6.
5. 5 Knapp FF, Ambrose KR, Goodman MM. New radioiodinated methylbranched fatty acid for cardiac studies. Eur J Nucl Med 1986;12:S39-44.
6. 6 Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125 15-(p-iodo-phenyl)-3-(R, S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-22.
7. 7 Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995;36:1043-50.
8. 123I-BMIPP). Eur J Nucl Med 1996;23:383-9.
9. 9 Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-67.
10. 10 Tamaki N, Kawamoto M, Yonekura Y, et al. Assessment of fatty acid metabolism using I-123 branched fatty acid metabolism using I-123 branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7:SII 41-7.
11. 11 De Geeter F, Franken PR, Knapp FF, et al. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and I-beta-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-91.
12. 12 Franken PR, De Geeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-65.
13. 13 Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994;35:1279-85.
14. 14 Matsunari I, Fujino S, Taki J, et al. Impaired fatty acid uptake in ischemic but viable myocardium identified by thallium-201 reinjection. Am Heart J 1996;131:458-65.
15. 15 Kurata C, Tawarahara K, Taguchi T, et al. Myocardial emission computed tomography with iodine-123-labelled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992;33:6-13.
16. 16 Takeshi Y, Chiba J, Abe S, et al. Heterogenous myocardial distribution of iodine-123 15(p-iodophenyl)-3R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992;19:775-82.
17. 17 Nakata T, Tanaka S, Hamagami S, et al. Detection of impaired fatty acid metabolism and dyskinesis in hypertrophic cardiomyopathy with iodine-123-BMIPP. J Nucl Med 1996;37:1679-81.
18. 18 Schiller NB, Shah PN, Crawford M. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
19. 19 Baandrup UB, Olsen EGJ. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy: 1. Morphological and morphometric aspects. Br Heart J 1981;45:475-86.
20. 20 Schwarz F, Mall G, Zebe H, et al. Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation 1984;70:923-8.
21. 21 Gelman EM, Smith JL, Beecher D, et al. Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography. Am J Med 1983;74:773-85.
22. 22 Hock A, Freundieb C, Vyska K, et al. Myocardial imaging and metabolic studies with (17-123) iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy. J Nucl Med 1983;24:22-8.
23. 23 Ugolini V, Hansen CL, Kulkarni PV, et al. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenylpentadecanoic acid and tomographic imaging. Am J Cardiol 1988;62:923-8.
24. 24 Unverferth DV, Magorien RD, Moeschberger ML, et al. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147-52.
25. 25 Nakayama Y, Shimizu G, Hirata Y, et al. Functional and histopathologic correlation in patients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis. J Am Coll Cardiol 1988;10:186-92.
26. 26 Doi Y, Chikamori T, Takata J, et al. Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy. Am J Cardiol 1991;67:188-93.
27. 27 Redfield MM, Gersh BJ, Bailey KR, et al. Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend. J Am Coll Cardiol 1993;22:1921-6.
28. 28 The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative north Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987;316:1429-35.
29. 29 Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 1993;342:1441-6.